Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionhyalurononglucosaminidase activity

HYAL1 HYAL3 HYAL2

1.83e-069573GO:0004415
GeneOntologyMolecularFunctionmethionine-tRNA ligase activity

MARS2 MARS1

8.01e-062572GO:0004825
GeneOntologyMolecularFunctionhyaluronoglucuronidase activity

HYAL3 HYAL2

8.01e-062572GO:0033906
GeneOntologyMolecularFunctionhexosaminidase activity

HYAL1 HYAL3 HYAL2

1.46e-0517573GO:0015929
GeneOntologyBiologicalProcesscellular response to UV-B

HYAL1 HYAL3 HYAL2

4.32e-0612573GO:0071493
GeneOntologyBiologicalProcessmonocyte activation

DYSF FER1L5 HYAL2

7.13e-0614573GO:0042117
GeneOntologyBiologicalProcessmonocyte activation involved in immune response

DYSF FER1L5

7.50e-062572GO:0002280
GeneOntologyBiologicalProcessmethionyl-tRNA aminoacylation

MARS2 MARS1

7.50e-062572GO:0006431
GeneOntologyBiologicalProcesshyaluronan catabolic process

HYAL1 HYAL3 HYAL2

1.59e-0518573GO:0030214
GeneOntologyBiologicalProcessresponse to UV-B

HYAL1 HYAL3 HYAL2

2.57e-0521573GO:0010224
GeneOntologyBiologicalProcesscellular response to interleukin-1

ADAMTS7 HYAL1 HYAL3 HYAL2

8.98e-0585574GO:0071347
GeneOntologyBiologicalProcessglycosaminoglycan catabolic process

HYAL1 HYAL3 HYAL2

9.38e-0532573GO:0006027
GeneOntologyBiologicalProcessaminoglycan catabolic process

HYAL1 HYAL3 HYAL2

1.58e-0438573GO:0006026
GeneOntologyBiologicalProcessmucopolysaccharide metabolic process

HYAL1 HYAL3 CHST12 HYAL2

1.69e-04100574GO:1903510
GeneOntologyBiologicalProcesshyaluronan metabolic process

HYAL1 HYAL3 HYAL2

1.84e-0440573GO:0030212
GeneOntologyBiologicalProcessresponse to interleukin-1

ADAMTS7 HYAL1 HYAL3 HYAL2

2.61e-04112574GO:0070555
GeneOntologyBiologicalProcesscarbohydrate derivative catabolic process

MGAT1 HYAL1 HYAL3 ENPP4 NUDT15 HYAL2

2.61e-04323576GO:1901136
GeneOntologyBiologicalProcessT-tubule organization

DYSF FER1L5

2.67e-049572GO:0033292
GeneOntologyBiologicalProcessglycosaminoglycan metabolic process

HYAL1 HYAL3 CHST12 HYAL2

3.50e-04121574GO:0030203
GeneOntologyBiologicalProcessaminoglycan metabolic process

HYAL1 HYAL3 CHST12 HYAL2

4.87e-04132574GO:0006022
DomainDysFC

DYSF FER1L5 TECPR1

1.08e-074573SM00694
DomainDysFN

DYSF FER1L5 TECPR1

1.08e-074573SM00693
DomainPeroxin/Ferlin

DYSF FER1L5 TECPR1

1.08e-074573IPR006614
DomainHyaluronidase

HYAL1 HYAL3 HYAL2

2.68e-075573IPR018155
DomainGlyco_hydro_56

HYAL1 HYAL3 HYAL2

2.68e-075573PF01630
DomaintRNA-synt_1g

MARS2 MARS1

9.15e-062572PF09334
DomainMet-tRNA_synth

MARS2 MARS1

9.15e-062572IPR014758
DomainMetRS_core

MARS2 MARS1

9.15e-062572IPR033911
DomainMethionyl/Leucyl_tRNA_Synth

MARS2 MARS1

9.15e-062572IPR015413
DomainC2_dom

PIK3C3 CAPN5 ASCC3 CADPS2 DYSF FER1L5

1.05e-05164576IPR000008
DomainFerA

DYSF FER1L5

2.74e-053572SM01200
DomainFerlin_A-domain

DYSF FER1L5

2.74e-053572IPR012560
DomainFerA

DYSF FER1L5

2.74e-053572PF08165
DomainC2

PIK3C3 CAPN5 CADPS2 DYSF FER1L5

6.08e-05137575SM00239
Domain-

PIK3C3 CAPN5 ASCC3 DYSF FER1L5

8.77e-051485752.60.40.150
DomainFerI

DYSF FER1L5

9.10e-055572SM01202
DomainFerB

DYSF FER1L5

9.10e-055572SM01201
DomainFerlin_B-domain

DYSF FER1L5

9.10e-055572IPR012561
DomainFerlin_C

DYSF FER1L5

9.10e-055572PF16165
DomainFerlin_C

DYSF FER1L5

9.10e-055572IPR032362
DomainFerIin_dom

DYSF FER1L5

9.10e-055572IPR012968
DomainFerI

DYSF FER1L5

9.10e-055572PF08151
DomainFerB

DYSF FER1L5

9.10e-055572PF08150
Domain-

HYAL1 HYAL3 HYAL2

2.84e-04425733.20.20.70
DomainRossmann-like_a/b/a_fold

MARS2 MARS1 NMNAT3

3.05e-0443573IPR014729
Domain-

MARS2 MARS1 NMNAT3

3.05e-04435733.40.50.620
DomainAldolase_TIM

HYAL1 HYAL3 HYAL2

3.27e-0444573IPR013785
Domain-

MARS2 MARS1

4.94e-04115721.10.730.10
DomainGlycoside_hydrolase_SF

HYAL1 HYAL3 HYAL2

5.67e-0453573IPR017853
DomainC2

CAPN5 CADPS2 DYSF FER1L5

6.85e-04131574PF00168
DomainC2

CAPN5 CADPS2 DYSF FER1L5

9.26e-04142574PS50004
DomaintRNAsynth_Ia_anticodon-bd

MARS2 MARS1

9.37e-0415572IPR009080
DomainTSP_1

CILP2 ADAMTS7 ISM2

9.40e-0463573PF00090
DomainTSP1

CILP2 ADAMTS7 ISM2

1.03e-0365573SM00209
DomainTSP1_rpt

CILP2 ADAMTS7 ISM2

1.03e-0365573IPR000884
DomainTSP1

CILP2 ADAMTS7 ISM2

1.03e-0365573PS50092
Domainaa-tRNA-synth_I_CS

MARS2 MARS1

1.36e-0318572IPR001412
DomainAA_TRNA_LIGASE_I

MARS2 MARS1

1.51e-0319572PS00178
Domain-

HERC1 TECPR1

2.03e-03225722.130.10.30
DomainRCC1/BLIP-II

HERC1 TECPR1

2.22e-0323572IPR009091
DomainAlkaline_phosphatase_core

STS ENPP4

4.02e-0331572IPR017850
DomainAlkaline_Pase-like_a/b/a

STS ENPP4

4.02e-0331572IPR017849
Domain-

STS ENPP4

4.02e-03315723.40.720.10
DomainEGF_3

HYAL1 HYAL3 EDIL3 HYAL2

5.73e-03235574PS50026
DomainEGF

HYAL1 HYAL3 EDIL3 HYAL2

5.73e-03235574SM00181
DomainEGF-like_dom

HYAL1 HYAL3 EDIL3 HYAL2

7.01e-03249574IPR000742
DomainEGF_1

HYAL1 HYAL3 EDIL3 HYAL2

7.61e-03255574PS00022
DomainEGF-like_CS

HYAL1 HYAL3 EDIL3 HYAL2

8.24e-03261574IPR013032
PathwayKEGG_MEDICUS_REFERENCE_DERMATAN_SULFATE_DEGRADATION

HYAL1 HYAL3 HYAL2

1.17e-068403M47607
PathwayREACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION

HYAL1 HYAL3 HYAL2

4.57e-0612403M660
PathwayREACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION

HYAL1 HYAL3 HYAL2

4.57e-0612403MM14868
PathwayREACTOME_HYALURONAN_METABOLISM

HYAL1 HYAL3 HYAL2

1.40e-0517403M666
PathwayREACTOME_HYALURONAN_METABOLISM

HYAL1 HYAL3 HYAL2

1.40e-0517403MM14864
PathwayKEGG_GLYCOSAMINOGLYCAN_DEGRADATION

HYAL1 HYAL3 HYAL2

2.72e-0521403M3624
PathwayREACTOME_SPHINGOLIPID_METABOLISM

CERK SUMF2 STS CERS4

2.32e-04107404M14857
PathwayREACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM

HYAL1 HYAL3 CHST12

3.35e-0448403MM14696
PathwayREACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM

HYAL1 HYAL3 CHST12

3.78e-0450403M678
PathwayREACTOME_GLYCOSAMINOGLYCAN_METABOLISM

HYAL1 HYAL3 CHST12 HYAL2

3.96e-04123404MM14623
PathwayREACTOME_GLYCOSAMINOGLYCAN_METABOLISM

HYAL1 HYAL3 CHST12 HYAL2

4.33e-04126404M695
PathwayREACTOME_GLYCOSPHINGOLIPID_METABOLISM

CERK SUMF2 STS

5.86e-0458403M576
PathwayREACTOME_THE_ACTIVATION_OF_ARYLSULFATASES

SUMF2 STS

6.00e-0413402M663
PathwayREACTOME_CS_DS_DEGRADATION

HYAL1 HYAL3

6.00e-0413402MM14805
PathwayREACTOME_CS_DS_DEGRADATION

HYAL1 HYAL3

6.99e-0414402M651
PathwayWP_GLYCOSAMINOGLYCAN_DEGRADATION

HYAL1 HYAL2

1.04e-0317402M39832
PathwayWP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES

CERK CERS4

1.75e-0322402M45544
PathwayREACTOME_SPHINGOLIPID_METABOLISM

CERK SUMF2 CERS4

2.23e-0392403MM15086
PathwayWP_SPHINGOLIPID_METABOLISM_OVERVIEW

CERK CERS4

2.26e-0325402MM15931
PathwayWP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY

CERK CERS4

2.44e-0326402M39784
PathwayKEGG_SELENOAMINO_ACID_METABOLISM

MARS2 MARS1

2.44e-0326402M7151
PathwayWP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY

CERK CERS4

2.44e-0326402MM15892
Pubmed

Characterization of the murine hyaluronidase gene region reveals complex organization and cotranscription of Hyal1 with downstream genes, Fus2 and Hyal3.

HYAL1 HYAL3 SEMA3B HYAL2

1.04e-10658411929860
Pubmed

Mammalian hyaluronidase induces ovarian granulosa cell apoptosis and is involved in follicular atresia.

HYAL1 HYAL3 HYAL2

4.40e-09358318653706
Pubmed

Involvement of hyaluronidases in colorectal cancer.

HYAL1 HYAL3 HYAL2

4.40e-09358320849597
Pubmed

Expression and regulation patterns of hyaluronidases in small cell lung cancer and glioma lines.

HYAL1 HYAL3 HYAL2

4.40e-09358312684632
Pubmed

Hyaluronidase expression and activity is regulated by pro-inflammatory cytokines in human airway epithelial cells.

HYAL1 HYAL3 HYAL2

4.40e-09358318390475
Pubmed

Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation.

HYAL1 HYAL3 HYAL2

4.40e-09358311296287
Pubmed

Expression and cellular localization of human hyaluronidase-2 in articular chondrocytes and cultured cell lines.

HYAL1 HYAL3 HYAL2

4.40e-09358316600643
Pubmed

Ultraviolet-B irradiation induces differential regulations of hyaluronidase expression and activity in normal human keratinocytes.

HYAL1 HYAL3 HYAL2

4.40e-09358321699545
Pubmed

Expression and activity of hyaluronidases HYAL-1, HYAL-2 and HYAL-3 in the human intervertebral disc.

HYAL1 HYAL3 HYAL2

4.40e-09358331758257
Pubmed

Hyaluronidases and CD44 undergo differential modulation during chondrogenesis.

HYAL1 HYAL3 HYAL2

1.76e-08458311944887
Pubmed

Construction of a 600-kilobase cosmid clone contig and generation of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3: progress toward the isolation of a lung cancer TSG.

HYAL1 SEMA3B HYAL2

1.76e-0845838603390
Pubmed

CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2.

HYAL1 HYAL3 HYAL2

1.76e-08458317170110
Pubmed

Skeletal and hematological anomalies in HYAL2-deficient mice: a second type of mucopolysaccharidosis IX?

HYAL1 HYAL3 HYAL2

1.53e-07758318772348
Pubmed

Regulation of hyaluronidase activity by alternative mRNA splicing.

HYAL1 HYAL3

2.73e-06258212084718
Pubmed

The suppressive role of HYAL1 and HYAL2 in the metastasis of colorectal cancer.

HYAL1 HYAL2

2.73e-06258230972813
Pubmed

Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX.

HYAL1 HYAL3

2.73e-06258210339581
Pubmed

Respective roles of hyaluronidases 1 and 2 in endogenous hyaluronan turnover.

HYAL1 HYAL2

2.73e-06258226887442
Pubmed

Hyaluronidase 1 and hyaluronidase 2 are required for renal hyaluronan turnover.

HYAL1 HYAL2

2.73e-06258225468725
Pubmed

Hyal-1 but not Hyal-3 deficiency has an impact on ovarian folliculogenesis and female fertility by altering the follistatin/activin/Smad3 pathway and the apoptotic process.

HYAL1 HYAL3

2.73e-06258221732362
Pubmed

Transforming growth factor-beta1 blocks the enhancement of tumor necrosis factor cytotoxicity by hyaluronidase Hyal-2 in L929 fibroblasts.

HYAL1 HYAL2

2.73e-06258211960552
Pubmed

Lack of hyaluronidases exacerbates renal post-ischemic injury, inflammation, and fibrosis.

HYAL1 HYAL2

2.73e-06258225715119
Pubmed

HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitro.

HYAL1 HYAL2

2.73e-06258218725949
Pubmed

Reactive oxygen species and hyaluronidase 2 regulate airway epithelial hyaluronan fragmentation.

HYAL1 HYAL2

2.73e-06258220554532
Pubmed

The DNA sequence, annotation and analysis of human chromosome 3.

HYAL1 HYAL3 ATP13A3 HYAL2

3.61e-066258416641997
Pubmed

Human hyaluronidases: electrophoretic multiple forms in somatic tissues and body fluids. Evidence for conserved hyaluronidase potential N-glycosylation sites in different mammalian species.

HYAL3 HYAL2

8.19e-06358210989127
Pubmed

The SH3 domain of p56lck is involved in binding to phosphatidylinositol 3'-kinase from T lymphocytes.

PIK3C3 LCK

8.19e-0635827504174
Pubmed

Hyaluronan degradation by HYAL2 is essential for odontoblastic differentiation and migration of mouse dental papilla cells.

HYAL1 HYAL2

8.19e-06358238490466
Pubmed

Polg2 is essential for mammalian embryogenesis and is required for mtDNA maintenance.

POLG EDIL3

8.19e-06358223197651
Pubmed

Patterns and rates of exonic de novo mutations in autism spectrum disorders.

CHD8 ZNF292

8.19e-06358222495311
Pubmed

Peritoneal adhesion and angiogenesis in ovarian carcinoma are inversely regulated by hyaluronan: the role of gonadotropins.

HYAL1 HYAL2

1.64e-05458220072653
Pubmed

Structural organization and chromosomal localization of Hyal2, a gene encoding a lysosomal hyaluronidase.

HYAL3 HYAL2

1.64e-0545829790770
Pubmed

Expression of hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in serous ovarian carcinomas: inverse correlation between HYAL1 and hyaluronan content.

HYAL1 HYAL2

2.72e-05558219435493
Pubmed

Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma.

HYAL1 HYAL2

2.72e-05558220875124
Pubmed

Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis.

HYAL1 HYAL3 HYAL2

3.56e-053858318267097
Pubmed

[Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer].

HYAL1 HYAL2

4.08e-05658219140316
Pubmed

bFGF induces changes in hyaluronan synthase and hyaluronidase isoform expression and modulates the migration capacity of fibrosarcoma cells.

HYAL1 HYAL2

4.08e-05658219577615
Pubmed

Chemerin, a novel adipokine in the regulation of angiogenesis.

TRHDE EDIL3

7.60e-05858220237162
Pubmed

Sulphatase activities are regulated by the interaction of sulphatase-modifying factor 1 with SUMF2.

SUMF2 STS

9.77e-05958215962010
Pubmed

Defining the membrane proteome of NK cells.

MGAT1 IPO9 PIK3C3 MARS1 MARF1 CHST12 ATP13A3 ENPP4 ASCC3

1.28e-04116858919946888
Pubmed

ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.

TOR1AIP2 SUMF2 STS HYAL3 SEMA3B CHST12 EDIL3 TAPBP MTDH

1.57e-04120158935696571
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

MARS1 HERC1 ASCC3 DYSF TAPBP ZNF292

1.78e-0449758636774506
Pubmed

HIV-1 Nef plays an essential role in two independent processes in CD4 down-regulation: dissociation of the CD4-p56(lck) complex and targeting of CD4 to lysosomes.

PIK3C3 LCK

1.78e-041258210208934
Pubmed

Down-regulation of LFA-1-mediated T cell adhesion induced by the HIV envelope glycoprotein gp160 requires phosphatidylinositol-3-kinase activity.

PIK3C3 LCK

1.78e-04125829341793
Pubmed

O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation.

CILP2 ADAMTS7 ISM2

2.73e-047558320637190
Pubmed

HIV Nef enhances Tat-mediated viral transcription through a hnRNP-K-nucleated signaling complex.

PIK3C3 LCK

2.83e-041558218854243
Pubmed

The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.

SEMA3B HYAL2

2.83e-041558211085536
Pubmed

Large-scale concatenation cDNA sequencing.

IPO9 PIK3C3 HERC1 TAPBP HMCES HYAL2

3.64e-045685869110174
Pubmed

A "double adaptor" method for improved shotgun library construction.

IPO9 PIK3C3 HERC1 TAPBP HMCES HYAL2

3.85e-045745868619474
Pubmed

FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells.

TOR1AIP2 IPO9 ASCC3 HMCES

4.40e-0421258433462405
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

MGAT1 ADAMTS7 MFHAS1 POLG CHD8 HERC1 MED13L DYSF

4.74e-04110558835748872
Pubmed

N6-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation.

MARS2 IPO9 ZNF589 ZNF292

4.80e-0421758434048709
Pubmed

Chromosomal localization of the genes for five zinc finger proteins expressed in mouse lens.

MGAT1 LCK

6.18e-04225827590745
Pubmed

CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity.

TOR1AIP2 SUMF2 IPO9 MARS1 MTDH

6.65e-0441858535338135
Pubmed

The role of PI3K in immune cells.

PIK3C3 LCK

7.37e-042458212660731
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

ENOSF1 BEST1 PIK3C3 MARS1 POLG FBXO42 ZNF589 SEMA3B CATSPERG

7.56e-04148958928611215
Pubmed

Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy.

PIK3C3 LCK

8.00e-042558217632570
Pubmed

LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.

TOR1AIP2 SUMF2 MGAT1 IPO9 MARS1 ASCC3 TAPBP

9.45e-0494258731073040
Pubmed

ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells.

MARS1 ASCC3 TAPBP MTDH

1.06e-0326858433024031
Pubmed

Semaphorin 3E/PlexinD1 signaling is required for cardiac ventricular compaction.

ADAMTS7 HYAL2

1.31e-033258231434798
Pubmed

Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.

SUMF2 MGAT1 HERC1 ASCC3

1.32e-0328558432838362
Pubmed

Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.

SUMF2 CADPS2 DYSF

1.48e-0313458324324551
InteractionPRG2 interactions

TOR1AIP2 CILP2 ADAMTS7 HYAL1 ZNF589 SEMA3B CHST12 TAPBP HYAL2

9.90e-08285579int:PRG2
InteractionMFAP4 interactions

CILP2 ADAMTS7 ZNF589 SEMA3B CHST12 HYAL2

2.63e-06139576int:MFAP4
InteractionCLGN interactions

FAM187B HYAL1 HYAL3 CHST12 ENPP4 GRM2 HYAL2

4.32e-06235577int:CLGN
InteractionCANX interactions

TRHDE TOR1AIP2 SUMF2 FAM187B IPO9 HYAL1 HYAL3 CLEC2D CHST12 PLEKHM3 ENPP4 HERC1 GRM2 MTDH

7.95e-0612615714int:CANX
InteractionB3GAT3 interactions

MGAT1 CLEC2D CHST12 ATP13A3 HYAL2

8.84e-0699575int:B3GAT3
InteractionBTNL2 interactions

CILP2 SEMA3B CHST12 TAPBP HYAL2

7.65e-05155575int:BTNL2
InteractionCLDN2 interactions

CLEC2D GRM2 MTDH

9.12e-0531573int:CLDN2
CytobandEnsembl 112 genes in cytogenetic band chr3p21

HYAL1 HYAL3 ZNF589 SEMA3B GRM2 HYAL2

3.04e-06316586chr3p21
Cytoband3p21.3

HYAL3 SEMA3B HYAL2

5.92e-05595833p21.3
GeneFamilyFerlin family

DYSF FER1L5

6.08e-056372828
GeneFamilyAminoacyl tRNA synthetases, Class I

MARS2 MARS1

6.82e-0419372131
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

CAPN5 CADPS2

2.46e-0336372823
ToppCellThalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora-Excitatory_Neuron.Slc17a6.Rora.Lypd6_(Parafasicular_nucleus_(PF))|Thalamus / BrainAtlas - Mouse McCarroll V32

CILP2 ADAMTS7 NUDT15

5.09e-05555837c8da8ca1776bb0abbfcf5c933b8817d64a0d3d7
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CLEC2D CHST12 ENPP4 LCK

6.80e-05168584b94b1f37c92e019d01ecfa3b7cc6797b6e4a56ff
ToppCell367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)

HYAL3 SEMA3B PLEKHM3 MED13L

7.45e-05172584da959c1abadafd79b7a0088a25eb8ef8efa3a0c2
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

HYAL1 DYSF EDIL3 HYAL2

7.45e-05172584c056d44e2e130ceccadfcdceb192a7f095d779c8
ToppCellAT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id

STS SEMA3B SCNN1G EDIL3

8.14e-05176584458720776b0151cd55acc352d509599cb62f0ca8
ToppCell10x5'-GI_large-bowel-Mast|GI_large-bowel / Manually curated celltypes from each tissue

BEST1 ADAMTS7 HYAL1 EDIL3

8.51e-05178584d10ed2543c96e1a2373f847e0b82144771e26d07
ToppCell10x5'-GI_large-bowel-Mast-Mast_cells|GI_large-bowel / Manually curated celltypes from each tissue

BEST1 ADAMTS7 HYAL1 EDIL3

8.51e-051785848fc5f735afa25ae43c2acb1c710ade6e9e093e3c
ToppCelldroplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SCNN1G TLE6 CAPN5 DYSF

9.07e-051815847af469f5bcb9b1ab3f35b2758bf2afb87e8eba57
ToppCelldroplet-Kidney-KIDNEY-1m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CERK HYAL3 MARF1 NUDT15

9.07e-05181584d90faa6115b408c9fbca61fc90ff951e070754ba
ToppCelldroplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTS7 SEMA3B CATSPERG EDIL3

9.27e-051825846fdaf3c8c3952a8f14dd7288e523ed58eb1d3517
ToppCelldroplet-Kidney-nan-3m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRHDE HYAL1 DYSF HYAL2

9.27e-05182584f4a5f1c3a04c0566eb96607dab7a0d9a5ebc3fd1
ToppCellE16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CERK FAM187B HYAL1 CLEC2D

1.01e-0418658439e475a3c167b33daa63b0c1bfa32451c5f46635
ToppCell356C-Endothelial_cells-Endothelial-E-|356C / Donor, Lineage, Cell class and subclass (all cells)

FAM187B DYSF HYAL2 TECPR1

1.01e-041865842e024097ee361eeb1d855a4edb8ac8cdad35da06
ToppCell356C-Endothelial_cells-Endothelial-E|356C / Donor, Lineage, Cell class and subclass (all cells)

FAM187B DYSF HYAL2 TECPR1

1.01e-04186584c3449e54454009973818fc1101933c6f0168258c
ToppCellE16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CERK FAM187B HYAL1 CLEC2D

1.01e-0418658402418c50fdcca549bf73dedf6199ab4a27862a9b
ToppCellAdult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor

HYAL1 CADPS2 DYSF HYAL2

1.05e-0418858402a62888e9db29d20133eeca1686d302545a39c9
ToppCell5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

STS DYSF HYAL2 TECPR1

1.07e-041895840739baad9a7da511dd3d7249f84299aee88370a1
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

CLEC2D LCK NMNAT3 ZNF292

1.09e-0419058491ba66d4b56c59523485b17738e93f14bb00afa4
ToppCell10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

HYAL1 CADPS2 BDKRB1 HYAL2

1.09e-0419058406bfb62b94b0faf467ef93d5bc5d08924c770098
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

HYAL1 DYSF EDIL3 HYAL2

1.12e-04191584f663131a4810584c5854bd64ee7991a237b7707f
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CLEC2D CHST12 ENPP4 LCK

1.14e-04192584fdc741e1846cfd8ed741b160e3c611c310c5d36d
ToppCell10x5'v1-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

ADAMTS7 GRM2 CADPS2 HYAL2

1.19e-041945848a4be91414a2e69dd410aa75791f16008204c9a1
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

HYAL1 DYSF EDIL3 HYAL2

1.19e-04194584ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7
ToppCellMild-CD8+_T|World / Disease group and Cell class

CLEC2D CHST12 HERC1 TAPBP

1.19e-04194584d64c2efb482bcdef9240977eae1023c4191286e7
ToppCellfacs-Aorta-Heart-3m-Endothelial-aorta_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTS7 DYSF EDIL3 HYAL2

1.21e-041955843969b8d5fcec8ef1831531a781f7bbcebab5a4ba
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CLEC2D CHST12 ENPP4 LCK

1.21e-041955841a7c2c4cf30df435770794a989be438579bf98f2
ToppCellmoderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CERK LCK TAPBP MTDH

1.23e-041965849152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da
ToppCellSepsis-URO-Lymphocyte-T/NK-gd_T|URO / Disease, condition lineage and cell class

CLEC2D CHST12 ENPP4 LCK

1.28e-04198584cb584f7754ef4e6d9ec7155022852f2d2676ab4f
ToppCellMultiple_Sclerosis|World / Disease, Lineage and Cell Type

CLEC2D CHST12 LCK MTDH

1.28e-0419858446728bb03f4b0d30ae9b62d984a6c2d00cfd370a
ToppCellmoderate-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CLEC2D CHST12 TAPBP MTDH

1.28e-041985840a868098b1ee4b28b2149ed766acb09e9c0ce14c
ToppCell10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ADAMTS7 DYSF BDKRB1 HYAL2

1.31e-04199584463ba77dc4c85eebb343f29a42c7ac889b0497c9
ToppCellMS-Multiple_Sclerosis|MS / Disease, condition lineage and cell class

CLEC2D CHST12 LCK MTDH

1.33e-04200584dc682a6d230932503565ee0e176b22577b5cf141
ToppCellSepsis-Int-URO-Lymphocyte-T/NK-NK_CD56bright|Int-URO / Disease, condition lineage and cell class

CLEC2D TLE6 CHST12 LCK

1.33e-04200584776b6590e21dbd80b6679433727070e06bf01f0f
ToppCellSubstantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Cadm2_(Cadm2_state)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

HYAL3 SEMA3B CATSPERG

1.67e-048258301a4d47d9e0dee68a5277ed1534338cec80f75d1
ToppCellSubstantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Cadm2_(Cadm2_state)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

HYAL3 SEMA3B CATSPERG

1.67e-0482583c1489097c291f413f3cfa5e26f8182ec872328fd
ToppCellThalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Thalamus / BrainAtlas - Mouse McCarroll V32

FAM187B CLEC2D ISM2

3.87e-041095834e4a884b8979f4ff8b232c1581ea78884dda29ed
ToppCellHippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6|Hippocampus / BrainAtlas - Mouse McCarroll V32

SCNN1G LCK GRM2

4.30e-041135836f270b7e59c18243e876311df721e948ce21e850
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Col6a1_Fezf2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

DRD5 GRM2 CADPS2

5.38e-04122583e96aec5af0ed1d8f4cc99fde59dd6998bbc1acbd
ToppCellLPS_only-Lymphocytic_NKT-T_cells-iNKT-MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CLEC2D CHST12 LCK

5.64e-0412458305e114fcfe84cfc8d92978a4eda6db4d8a616e0e
ToppCellPBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SEMA3B PTGES3L ISM2

7.38e-0413658327a41463e6f16deb5b1d4f17fefded9959038c07
ToppCellPBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SEMA3B PTGES3L ISM2

7.38e-0413658388b5c839d0446c6d6b7e81fc4d48f5e7e96eea11
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SCNN1G GRM2 CADPS2

8.54e-04143583990844ca674d30b2924c74b45bed4fdfb8463fa7
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SCNN1G TLE6 CADPS2

8.89e-04145583bfa196ac1db7acbfcbb2ba9f137036a95e16e091
ToppCell368C-Lymphocytic-CD4_T-cell-Treg_cell_1|368C / Donor, Lineage, Cell class and subclass (all cells)

MARS2 CLEC2D LCK

9.43e-0414858380470353e12599440f711b6e107730763376d04d
ToppCellP03-Epithelial-epithelial_progenitor_cell-epi_progenitor|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

FAM187B TLE6 NMNAT3

9.99e-04151583fce04bce66411c21cd5d4d41375f26f1f50f3348
ToppCell368C-Lymphocytic-CD4_T-cell-Treg_cell_4|368C / Donor, Lineage, Cell class and subclass (all cells)

MFHAS1 CLEC2D LCK

9.99e-041515835d64655b6b09cc0a6d44629a31048b787a0916c5
ToppCellLeuk-UTI-Lymphocyte-T_NK-CD4_CTL|Leuk-UTI / Disease, Lineage and Cell Type

CLEC2D CHST12 LCK

1.06e-03154583170a421fd69dba2929568c72e983ae9cfaf2aabc
ToppCellsaliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

MFHAS1 LCK GRM2

1.06e-03154583ec920cae12ea1d14b6c973f6e903f895f80e3c50
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

MFHAS1 SCNN1G CADPS2

1.12e-031575832c5295043611bac7dfa4aef2146681bce4a33a8f
ToppCellLeuk-UTI-Lymphocyte-T_NK-gdT|Leuk-UTI / Disease, Lineage and Cell Type

CLEC2D CHST12 LCK

1.14e-03158583c4b0af25608cee3d0d2b0193f5ff45d9dc87078b
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CAPN5 CADPS2 BDKRB1

1.18e-031605836dc37fd940d5d8088046b02079c2026733817aac
ToppCellICU-NoSEP-Lymphocyte-T_NK-gdT|ICU-NoSEP / Disease, Lineage and Cell Type

CILP2 CLEC2D CHST12

1.18e-031605832798c5bd971407f27dd4d3a4831d63d9c88003c3
ToppCellURO-Lymphocyte-T_NK-CD4_CTL|URO / Disease, Lineage and Cell Type

CLEC2D CHST12 LCK

1.22e-031625831afeeb17e263cf625a4f285203cf82f973735193
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CLEC2D LCK HMCES

1.22e-0316258319395bdb282b4a2d88cd33191af12c24a88c3d16
ToppCellfacs-Thymus-Thymus_Flowthrough-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MARF1 CLEC2D LCK

1.22e-031625837e6d20704d77b28512690f882f9ddbbd9c5c3228
ToppCellfacs-Thymus-Thymus_Flowthrough|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MARF1 CLEC2D LCK

1.22e-031625832c193f766f2cefe67682f34325d1de6aed778f49
ToppCell367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

SEMA3B PLEKHM3 CATSPERG

1.24e-0316358363b0badaee3b2d827b1f4524510e3384d8f8fcde
ToppCell390C-Lymphocytic-NK_cells-NK_cell_B2|390C / Donor, Lineage, Cell class and subclass (all cells)

CHST12 LCK GRM2

1.24e-03163583036e65de0f8fc391f3e4d299bf4c05ee5c3b5a37
ToppCellBAL-Mild-Lymphocyte-T/NK-CD8+_T-MAIT-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CERK CLEC2D LCK

1.31e-03166583bb93db4613c067c56614ab1ca39e73ee46484387
ToppCellBAL-Mild-Lymphocyte-T/NK-CD8+_T-MAIT|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CERK CLEC2D LCK

1.31e-03166583c1f17a028bb27b8f202bcfffa7de7373b1cdd990
ToppCell3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-TRGV5/7_gdT|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LCK HERC1 TECPR1

1.33e-0316758318e336faa2d2429ab49d1c6ae9bbf9923d74aa8d
ToppCellAdult-Immune-natural_killer_cell-D122|Adult / Lineage, Cell type, age group and donor

CLEC2D CHST12 LCK

1.33e-03167583ff1ce3b1a2d91d2ad979f25899db4f4eeb865892
ToppCellCV-Mild-6|CV / Virus stimulation, Condition and Cluster

STS SNRNP35 TLE6

1.33e-03167583cf2ed0b6d17a16f9a2318879ce8856d5983ad3cf
ToppCellwk_20-22-Hematologic-Myeloid-CMP|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

MARS2 HYAL3 PTGES3L

1.36e-03168583e223bd7ae2a28c007e8b365f30d50d3bee83ba38
ToppCell356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|356C / Donor, Lineage, Cell class and subclass (all cells)

CILP2 CLEC2D LCK

1.36e-031685839d6ca10c272aea28082c09d469940f7232f6461c
ToppCell3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-TRGV5/7_gdT|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MFHAS1 LCK HERC1

1.36e-03168583235c368669c017e13a7312fce3d8b91d7d106c7a
ToppCellCOVID-19_Severe-CD4+_CTL|World / disease group, cell group and cell class

CLEC2D CHST12 LCK

1.38e-031695838c8168ac93a808d7b4756e4491db2b2979df1c1f
ToppCellsevere-HSPC|World / disease stage, cell group and cell class

HYAL3 PTGES3L GRM2

1.38e-03169583b0421b73bfdc92f7a2762b4b670b9eae124aa702
ToppCellICU-NoSEP-Lymphocyte-T_NK-CD4_CTL|ICU-NoSEP / Disease, Lineage and Cell Type

CLEC2D CHST12 LCK

1.38e-03169583cbda36f32bd78322dcfe303a44413415d08e5ea3
ToppCellP15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

ADAMTS7 HYAL3 TLE6

1.40e-03170583ba4ba66b624089ed50a9083176386c7941b4c7a3
ToppCellSevere-Lymphoid-T-|Severe / Condition, Lineage, Cell class and cell subclass

CLEC2D CHST12 LCK

1.40e-031705835788e1158fde036937d41708e9db3222ca351eb1
ToppCell10x5'-Lung-Lymphocytic_T_CD8-Trm_gut_CD8|Lung / Manually curated celltypes from each tissue

CLEC2D CHST12 LCK

1.43e-03171583c8ccb7795ce8321739e3bc07db2ffc183d04e660
ToppCell390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|390C / Donor, Lineage, Cell class and subclass (all cells)

CLEC2D CHST12 LCK

1.43e-03171583d6d8ea45b443d95f64720c9bc07d324148f5b239
ToppCellnormal-na-Lymphocytic_NK-natural_killer_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

CHST12 CATSPERG HYAL2

1.43e-03171583d339840626211a7bf1a9eb8f14d6c9509ab05e1c
ToppCellEndothelial-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id

ADAMTS7 DYSF HYAL2

1.45e-031725838a527dff06d841a86c7eb04a1dd9630787294da4
ToppCellURO-Lymphocyte-T_NK-gdT|URO / Disease, Lineage and Cell Type

CLEC2D CHST12 LCK

1.45e-0317258397b1eb95234639fcaa5ea3c4ba7ec2f4eb929dbf
ToppCelldroplet-Lung-immune-endo-depleted-3m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FAM187B CHST12 NUDT15

1.48e-031735833c51e7bda1835c25915e50c801b0d643979971a3
ToppCellmild_COVID-19_(asymptomatic)-gd_T|World / disease group, cell group and cell class (v2)

CLEC2D CHST12 LCK

1.48e-03173583b6615ff02f5017d7150b1e33b53f8c7a26081a0d
ToppCelldroplet-Lung-immune-endo-depleted-3m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FAM187B CHST12 NUDT15

1.48e-03173583a042f78a4c69fcc6b5ca76e9bf01e34cee54c81c
ToppCell3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DYSF FER1L5 HYAL2

1.48e-03173583b57d14e2c2368304cb903562d06ce8228f53857c
ToppCelldroplet-Marrow-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CERK MGAT1 TAPBP

1.50e-03174583a188ec192c378f731af1c95eb8f1392a2bb18c26
ToppCellImmune_cells-pro-B|World / Lineage and Cell class

CERK ADAMTS7 HMCES

1.50e-03174583e173adbf5789dfa20f3cbc668efde5f0992ac219
ToppCellInt-URO-Lymphocyte-T_NK-NK_CD56bright|Int-URO / Disease, Lineage and Cell Type

TLE6 CHST12 LCK

1.50e-0317458393c7acd5941a5f235ec4c57461f78ee2871e7336
ToppCellHealthy_Control-Lymphoid-NK-CD8_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass

CLEC2D LCK CERS4

1.50e-031745835dddb822fa51b4020e4d9318acacd19c726091d6
ToppCellfacs-SCAT-Fat-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CILP2 LCK NUDT15

1.50e-0317458387fa5deff5c1aabb342d674f05ad17c4c0e50d01
ToppCell5'-Adult-LymphNode-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CLEC2D LCK FER1L5

1.53e-03175583dddeced0cfcf71d03bcf349983908b3bfb0ab51d
ToppCellwk_20-22-Hematologic_Lymphocytic-B-Pro-B/Pre-B_transition|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

STS MED13L HMCES

1.53e-03175583f86d2d212f8314b2410d5d84ef092b0b38607ea4
ToppCellThalamus-Neuronal-Excitatory|Thalamus / BrainAtlas - Mouse McCarroll V32

HERC1 GRM2 TECPR1

1.55e-03176583d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66
ToppCellTCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9

CILP2 STS DYSF

1.55e-031765830923b01137d6f9956ca815b41102c81e82624065
ToppCellInt-URO-Lymphocyte-T_NK-gdT|Int-URO / Disease, Lineage and Cell Type

CLEC2D CHST12 LCK

1.55e-0317658315016a73c953d8d3e7c32a05ead5e7261f9914ca
ToppCellClub_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id

SEMA3B SCNN1G CAPN5

1.55e-0317658388c4ed0ab4a4ede8cad21385d799b723b5786cd9
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TRHDE EDIL3 NMNAT3

1.55e-03176583327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCell3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HYAL1 DYSF HYAL2

1.55e-031765835d3b2395bb842eea39175f5af6a4c76527e2fc31
ToppCellCOVID-19_Severe-CD4+_CTL|COVID-19_Severe / disease group, cell group and cell class

CLEC2D CHST12 LCK

1.58e-0317758334e9455790bae905dd91923792f4109d18b7686e
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TRHDE EDIL3 NMNAT3

1.58e-03177583da8802a6351d3e510822f82e2fde8a4314a2216e
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

MFHAS1 LCK HMCES

1.58e-03177583f4ddf0ef0eade13b9835a5684a8dbb6f71be4697
ToppCelldroplet-Marrow-BM-30m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MFHAS1 LCK NMNAT3

1.58e-03177583650095a17e1a39caea74a6e89646565b9332af5d
ToppCell3'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HYAL1 DYSF HYAL2

1.58e-03177583d6596a0b6fd146fefc27717c1a7dbaa3774cc644
ToppCelldroplet-Marrow-BM-30m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MFHAS1 LCK NMNAT3

1.58e-03177583d1af0cb4b1fb03f04cff5add85e29be8fb8f4dcb
ToppCell390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|390C / Donor, Lineage, Cell class and subclass (all cells)

CLEC2D CHST12 LCK

1.60e-03178583375c9449be570b4aed83611f9c6fe1665e677818
DiseaseAttention deficit hyperactivity disorder

DRD5 STS ZNF292

1.34e-0524573C1263846
Diseasethioredoxin domain-containing protein 12 measurement

HYAL1 ZNF589 GRM2

5.94e-0539573EFO_0008298
Diseaselimb-girdle muscular dystrophy (implicated_via_orthology)

DYSF FER1L5

7.65e-057572DOID:11724 (implicated_via_orthology)
DiseaseKeloid

HYAL1 HYAL2

4.89e-0417572EFO_0004212
Diseasecerebellum white matter volume change measurement, age at assessment

TRHDE ADAMTS7

6.81e-0420572EFO_0008007, EFO_0021498
DiseaseAttention Deficit Disorder

DRD5 STS

8.26e-0422572C0041671
DiseaseMinimal Brain Dysfunction

DRD5 STS

8.26e-0422572C1321905
DiseaseEpilepsy, Benign Psychomotor, Childhood

GRM2 BDKRB1

9.04e-0423572C0393672
DiseaseEpilepsy, Lateral Temporal

GRM2 BDKRB1

9.04e-0423572C0393682
DiseaseUncinate Epilepsy

GRM2 BDKRB1

9.04e-0423572C0014558
DiseaseEpilepsy, Temporal Lobe

GRM2 BDKRB1

9.04e-0423572C0014556
Diseaseresponse to venlafaxine

POLG DYSF

1.07e-0325572EFO_0006328
Diseaseobese body mass index status

PIK3C3 SEMA3B

1.86e-0333572EFO_0007041

Protein segments in the cluster

PeptideGeneStartEntry
VTPVWWEDVWLKEGF

TRHDE

451

Q9UKU6
ADPVHDPTWRWWANN

CATSPERG

701

Q6ZRH7
DPTWRWWANNKQDQD

CATSPERG

706

Q6ZRH7
PFWAENIWNQFNWPF

BDKRB1

91

P46663
WFPVVDQLEVPTTWW

CHD8

1611

Q9HCK8
NEWFWQDRFWLPPNV

CERS4

6

Q9HA82
FWVKQQPWYEVWHPK

ATP13A3

1026

Q9H7F0
PWNNSRNPWFREFWE

GRM2

336

Q14416
TRWWNQYENLPWPDR

BEST1

91

O76090
LWQKVIPDWKEQEWD

CAPN5

96

O15484
WNGPWSDTSEEWQKV

CAPN5

291

O15484
EQPCPARWWAGEWQL

ADAMTS7

876

Q9UKP4
NLANWTPWEEDFWEP

DRD5

196

P21918
WVLDLEQWAWSKPNI

FBXO42

261

Q6P3S6
LLPQNSSWKAWQVPW

C22orf46

161

C9J442
WSFPLEWAPQNLTRW

TOR1AIP2

66

Q9H496
DWRPVWVRNWQDKDV

HYAL2

136

Q12891
KELWIFWWGDEPNLV

MED13L

81

Q71F56
WAELEPKWPKAFWDD

MGAT1

276

P26572
FQPPQAQRLWLSWWD

MFHAS1

671

Q9Y4C4
NVEPEKNESWEWVPW

NUDT15

111

Q9NV35
KNESWEWVPWEELPP

NUDT15

116

Q9NV35
PASWNPNEWAWLECF

HERC1

3916

Q15751
AVWDLWAKQEGKPVW

ENOSF1

121

Q7L5Y1
WDQGWLAPGDWVFKD

ISM2

306

Q6H9L7
LVAPDWGWVDCWEVP

C19orf85

191

A0A1B0GUS0
NDKDPFWWNEAVPIW

ENPP4

106

Q9Y6X5
EDPWLWDLEWDLQEF

POLG

481

P54098
TQKPQKPWWEDEWEV

LCK

226

P06239
KPWWEDEWEVPRETL

LCK

231

P06239
ESPWEALDWGQKLWE

PLEKHM3

291

Q6ZWE6
LINAWTAAENDRWPW

EDIL3

201

O43854
RWKWAQVTFWCPEEQ

CERK

96

Q8TCT0
AGPAVLDWEEWCPLW

HYAL3

121

O43820
AWWPDLLAEHAEKFW

CADPS2

866

Q86UW7
GWLQQDNDAKPWLWK

MARF1

16

Q9Y4F3
NSDWNAPAEEWGNWV

MTDH

391

Q86UE4
AHWDWPEAWPQLFNL

IPO9

136

Q96P70
EAWRPRWAFNWDTKD

HYAL1

131

Q12794
GSKQLIFTWWEPWQD

FAM187B

136

Q17R55
WQKAKEWWAWKQAPP

SCNN1G

566

P51170
IECPLGWKWEDEEWS

DYSF

986

O75923
PENWEKVWDNWRLLT

HMCES

161

Q96FZ2
LWWLPVEKAFWRQPA

SUMF2

116

Q8NBJ7
TDFQPPLGWHWQDSW

FER1L5

821

A0AVI2
PLGWHWQDSWTVEPQ

FER1L5

826

A0AVI2
FKETIWNDAFWQNPW

SMIM6

6

P0DI80
FSTRWNWNEWLKLPV

PIK3C3

81

Q8NEB9
DQFSWNNFLWKPWLQ

STS

546

P08842
VGEPWWIWVEDPTND

ASCC3

1216

Q8N3C0
SWTGDLLAWWPNPQE

CILP2

921

Q8IUL8
WEEDWFAKIPLAWRQ

CHST12

376

Q9NRB3
QPWKWINGTEWTRQF

CLEC2D

141

Q9UHP7
WNWIQLWNYAQPPDV

SUN5

226

Q8TC36
AWPAPVEWREECNWA

SEMA3B

91

Q13214
TKPPSLQWAWVSDWF

TECPR1

861

Q7Z6L1
VAFAAWDDDEPWGPW

TAPBP

236

O15533
LKTQWPFDPEFWDWK

ZNF292

436

O60281
WQEREPTRVWPDNDW

SNRNP35

211

Q16560
APWKLNWESPVDAPW

MARS2

491

Q96GW9
WTAEALPAKDSAWPW

ZNF589

11

Q86UQ0
KPVWLSVDFDNWRDW

PTGES3L

106

E9PB15
NYTDQWERWWKNPEQ

MARS1

531

P56192
WERWWKNPEQVDLYQ

MARS1

536

P56192
QPETQLFWDKEPWFW

TLE6

141

Q9H808
DWIRVDPWESEQAQW

NMNAT3

76

Q96T66